Brazil Regulator Backs Hapvida-Notre Dame Deal Without Remedies

Brazil antitrust regulator Cade’s superintendence approved Hapvida-Notre Dame Intermedica deal without remedies, Hapvida in a filing.

• Next step includes the publication of the order and a period of 15 days for any possible manifestations by Cade court, company said
• NOTE: Brazil’s Hapvida and Intermedica Agree on Merger: M&A Snapshot
• NOTE: Hapvida Sees Small Risk for Intermedica Deal at Brazil Regulator

Original Story:

Hapvida: Superintendência Cade aprova acordo com Notre Dame

To contact the translator on this story:
Taís Fuoco in Sao Paulo at tfuoco1@bloomberg.net

Reporter on the original story:
Vinícius Andrade in São Paulo at vandrade3@bloomberg.net

Editors responsible for ...